Table 2 of
Simpson, Mol Vis 2011; 17:2649-2654.
Table 2. Crystal volume index (CVI) in untreated and cysteamine treated eyes.
Eye ID |
CVI at baseline (Mean±SD) |
CVI after treatment (Mean±SD) |
% change |
|---|---|---|---|
| Untreated | |||
| 246 OD | SCAR | SCAR | SCAR |
| 246 OS | 0.76±0.13 | SCAR | SCAR |
| 247 OD | 0.44±0.06 | SCAR | SCAR |
| 247 OS | 0.41±0.15 | 1.77±0.52 | 336 |
| 275 OD | 0.25±0.06 | 0.40±0.07 | 61 |
| 275 OS | 0.24±0.03 | 0.93±0.18 | 283 |
| 156 OD | SCAR | SCAR | SCAR |
| 156 OS | 3.48±0.32 | 3.92±0.59 | 12 |
| 277 OD | 0.46±0.26 | 0.78±0.45 | 67 |
| 277 OS | 0.53±0.27 | 0.67±0.39 | 25 |
| Mean CVI | 0.82 | 1.41 | 173% |
| Cysteamine treated | |||
| 276 OD | 0.38±0.13 | 0.41±0.17 | 9 |
| 276 OS | 0.77±0.40 | 0.60±0.19 | -21 |
| 278 OD | 0.43±0.09 | 0.49±0.08 | 16 |
| 278 OS | 0.48±0.01 | 0.37±0.17 | -22 |
| 279 OD | 0.25±0.15 | 0.60±0.13 | 137 |
| 279 OS | 0.17±0.11 | 0.28±0.13 | 65 |
| 249 OS | 0.82±0.26 | 0.73±0.01 | -10 |
| 249 OD | 2.45±0.53 | 1.13±0.55 | -53 |
| 245 OD | 0.55±0.17 | 2.87±2.32 | 416 |
| 245 OS | SCAR | SCAR | SCAR |
| Mean CVI | 0.70 | 0.83 | 15% |